New Imaging Technology Offers Hope for Diagnosing CTE in Living Patients
Doctors are hopeful that new imaging technology, utilizing cellular tracing and PET scanning to detect tau protein buildup, could enable the diagnosis of CTE in living patients. This breakthrough, stemming from research at institutions like George Washington University Hospital, could…
Atlanta, GA, August 29, 2026 —
A novel imaging technology employing cellular tracing and Positron Emission Tomography (PET) scanning shows promise for diagnosing Chronic Traumatic Encephalopathy (CTE) in living individuals. This development is generating optimism among medical professionals for its potential to revolutionize the understanding and treatment of head trauma-related conditions.
The technology focuses on detecting the buildup of tau protein in the brain, a key hallmark associated with CTE. Currently, definitive diagnosis of CTE is only possible through post-mortem examination of brain tissue. The ability to identify tau protein accumulation in living patients through advanced imaging could mark a significant leap forward.
Research institutions, including George Washington University Hospital, are involved in exploring this new diagnostic approach. The breakthrough could accelerate efforts in treatment research for conditions resulting from head trauma, such as concussions and repeated head impacts.
Experts anticipate that this technology may seek and potentially receive federal approval for widespread use within the next two years. Such approval would pave the way for broader clinical application, enabling more accurate and timely diagnoses for individuals at risk of developing CTE.
Story summarized from the original created by Brendan Cullerton on www.atlantanewsfirst.com, see more information here.
